메뉴 건너뛰기
JAMA Neurology
Volumn 71, Issue 11, 2014, Pages 1351-1352
The future of research in Parkinson disease
Author keywords

[No Author keywords available]
Indexed keywords

9 FLUOROPROPYL (1) DIHYDROTETRABENAZINE F 18; ALPHA SYNUCLEIN; ANTIOXIDANT; ANTIPARKINSON AGENT; AZD 3241; ENZYME INHIBITOR; EXENDIN 4; INOSINE; ISRADIPINE; PIOGLITAZONE; RADIOLIGAND; RP 103; UNCLASSIFIED DRUG;
EID: 84919402588     PISSN: 21686149     EISSN: 21686157     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.1717     Document Type: Short Survey
Times cited : (32)
References (8)
  • 1
    • 84899013764 scopus 로고    scopus 로고
    • Parkinson disease subtypes
    • Thenganatt MA, Jankovic J. Parkinson disease subtypes. JAMA Neurol. 2014;71(4):499-504.
    • (2014) JAMA Neurol , vol.71 , Issue.4 , pp. 499-504
    • Thenganatt, M.A.1    Jankovic, J.2
  • 2
    • 78651315861 scopus 로고    scopus 로고
    • Preclinical biomarkers of Parkinson disease
    • Wu Y, Le W, Jankovic J. Preclinical biomarkers of Parkinson disease. Arch Neurol. 2011;68(1):22-30.
    • (2011) Arch Neurol , vol.68 , Issue.1 , pp. 22-30
    • Wu, Y.1    Le, W.2    Jankovic, J.3
  • 3
    • 84894528843 scopus 로고    scopus 로고
    • Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease
    • Murphy KE, Gysbers AM, Abbott SK, et al. Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease. Brain. 2014;137(pt 3):834-848.
    • (2014) Brain , vol.137 , pp. 834-848
    • Murphy, K.E.1    Gysbers, A.M.2    Abbott, S.K.3
  • 4
    • 84897977607 scopus 로고    scopus 로고
    • Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys
    • Recasens A, Dehay B, Bové J, et al. Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys. Ann Neurol. 2014;75(3):351-362.
    • (2014) Ann Neurol , vol.75 , Issue.3 , pp. 351-362
    • Recasens, A.1    Dehay, B.2    Bové, J.3
  • 5
    • 84897076939 scopus 로고    scopus 로고
    • Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease
    • Palfi S, Gurruchaga JM, Ralph GS, et al. Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease. Lancet. 2014;383(9923):1138-1146.
    • (2014) Lancet , vol.383 , Issue.9923 , pp. 1138-1146
    • Palfi, S.1    Gurruchaga, J.M.2    Ralph, G.S.3
  • 6
    • 84903441419 scopus 로고    scopus 로고
    • α-Synuclein immunotherapy blocks uptake and templated propagation of misfolded α-synuclein and neurodegeneration
    • Tran HT, Chung CH, Iba M, et al. α-Synuclein immunotherapy blocks uptake and templated propagation of misfolded α-synuclein and neurodegeneration. Cell Rep. 2014;7(6):2054-2065.
    • (2014) Cell Rep , vol.7 , Issue.6 , pp. 2054-2065
    • Tran, H.T.1    Chung, C.H.2    Iba, M.3
  • 7
    • 84892516916 scopus 로고    scopus 로고
    • Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease
    • Olanow CW, Kieburtz K, Odin P, et al; LCIG Horizon Study Group. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease. Lancet Neurol. 2014;13(2):141-149.
    • (2014) Lancet Neurol , vol.13 , Issue.2 , pp. 141-149
    • Olanow, C.W.1    Kieburtz, K.2    Odin, P.3
  • 8
    • 84895904524 scopus 로고    scopus 로고
    • Pimavanserin for patients with Parkinson's disease psychosis
    • Cummings J, Isaacson S, Mills R, et al. Pimavanserin for patients with Parkinson's disease psychosis. Lancet. 2014;383(9916):533-540.
    • (2014) Lancet , vol.383 , Issue.9916 , pp. 533-540
    • Cummings, J.1    Isaacson, S.2    Mills, R.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.